ivabradine hydrochloride

Procoralan

Pages intended for UK practising Healthcare Professionals only

Therapeutic indications1

Symptomatic treatment of chronic stable angina pectoris

Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate 70 bpm.  Ivabradine is indicated -

  • in adults unable to tolerate or with a contra-indication to the use of beta-blockers
  • or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose

Treatment of chronic heart failure

Ivabradine is indicated in chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

 

SPC

PIL

PI

Frequently Asked Questions

 

1. Procoralan Summary of Product Characteristics

 

UK14WEB0020d(4)  DoP: September 2016